• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Early response and local control of stage I non-small-cell lung cancer after stereotactic radiotherapy: difference by histology.立体定向放疗后 I 期非小细胞肺癌的早期反应和局部控制:组织学差异。
Cancer Sci. 2013 Jan;104(1):130-4. doi: 10.1111/cas.12048. Epub 2012 Dec 4.
2
Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer.原发性或转移性肺癌的立体定向放射治疗的结果和预后因素。
J Thorac Oncol. 2010 Apr;5(4):526-32. doi: 10.1097/JTO.0b013e3181cbf622.
3
Outcome Study of Cobalt Based Stereotactic Body Radiation Therapy for Patients with Inoperable Stage III Non-small Cell Lung Cancer.钴基立体定向体部放射治疗不可切除Ⅲ期非小细胞肺癌患者的疗效研究
Technol Cancer Res Treat. 2015 Oct;14(5):539-45. doi: 10.7785/tcrt.2012.500425. Epub 2014 Nov 26.
4
Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.非小细胞肺癌原发性放射治疗中的剂量、体积与肿瘤控制预测
Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):382-9. doi: 10.1016/s0360-3016(01)01823-5.
5
A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence.单中心立体定向体部放疗治疗非小细胞肺癌的回顾性长期随访研究:迟发局部复发的发生率。
Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1228-1236. doi: 10.1016/j.ijrobp.2018.01.050. Epub 2018 Jan 31.
6
Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy.非小细胞肺癌的组织学可预测立体定向体部放疗的疗效。
Radiother Oncol. 2017 Nov;125(2):317-324. doi: 10.1016/j.radonc.2017.08.029. Epub 2017 Sep 14.
7
A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.单次分割碳离子放疗治疗Ⅰ期周围型非小细胞肺癌的剂量递增临床试验。
J Thorac Oncol. 2017 Apr;12(4):673-680. doi: 10.1016/j.jtho.2016.12.012. Epub 2016 Dec 19.
8
Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.立体定向体部放疗与常规放疗治疗早期非小细胞肺癌患者的疗效比较:一项局部失败率和生存率的更新回顾性研究。
Acta Oncol. 2013 Oct;52(7):1552-8. doi: 10.3109/0284186X.2013.813635. Epub 2013 Aug 1.
9
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.立体定向体部放疗在以磨玻璃密度为主的肺部肿瘤患者中的应用。
J Radiat Res. 2020 May 22;61(3):426-430. doi: 10.1093/jrr/rraa015.
10
Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.单纯放疗用于医学上无法手术的Ⅰ期非小细胞肺癌:杜克大学的经验。
Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):149-54. doi: 10.1016/s0360-3016(97)00589-0.

引用本文的文献

1
Comparative survival analysis of stage T1-T2N0M0 lung squamous cell carcinoma and adenocarcinoma using SEER data, and nomogram analysis for early-stage lung squamous cell carcinoma.利用监测、流行病学和最终结果(SEER)数据对T1-T2N0M0期肺鳞状细胞癌和腺癌进行生存比较分析,并对早期肺鳞状细胞癌进行列线图分析。
Transl Cancer Res. 2025 Mar 30;14(3):1691-1709. doi: 10.21037/tcr-24-1602. Epub 2025 Mar 27.
2
SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma.SET结构域蛋白2调控基因转录模式并与肺腺癌的放射敏感性相关。
Front Genet. 2022 Aug 10;13:935601. doi: 10.3389/fgene.2022.935601. eCollection 2022.
3
Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.立体定向体部放疗与射频消融治疗早期非小细胞肺癌的比较:一项系统评价和荟萃分析
Ann Transl Med. 2022 Jan;10(2):104. doi: 10.21037/atm-21-6256.
4
Prognostic Radiological Tools for Clinical Stage IA Pure Solid Lung Cancer.临床IA期纯实性肺癌的预后放射学工具
Curr Oncol. 2021 Sep 30;28(5):3846-3856. doi: 10.3390/curroncol28050328.
5
Correspondence: Abnormal Nuclear Variations in Response to Radiotherapy: As a Tool in Treatment Planning and Assessment of Prognosis.通信:放疗引起的异常核变化:作为治疗计划和预后评估的工具
J Clin Diagn Res. 2017 May;11(5):AL01-AL02. doi: 10.7860/JCDR/2017/26339.9832. Epub 2017 May 1.
6
Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer.老年医学上无法手术的早期非小细胞肺癌的机器人立体定向体部放射治疗
Lung Cancer (Auckl). 2013 Aug 6;4:35-42. doi: 10.2147/LCTT.S48121. eCollection 2013.
7
Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.使用实时肿瘤追踪放射治疗系统对I期和IIA期非小细胞肺癌患者进行立体定向体部放射治疗的临床结果。
Radiat Oncol. 2017 Jan 5;12(1):3. doi: 10.1186/s13014-016-0742-3.
8
Impact of early tumor reduction on outcome differs by histological subtype in stage III non-small-cell lung cancer treated with definitive radiotherapy.在接受根治性放疗的III期非小细胞肺癌中,早期肿瘤缩小对预后的影响因组织学亚型而异。
Int J Clin Oncol. 2016 Oct;21(5):853-861. doi: 10.1007/s10147-016-0982-0. Epub 2016 Apr 28.
9
Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?早期非小细胞肺癌的立体定向体部放射治疗:何时以及为何是合适的治疗方法?
J Adv Pract Oncol. 2015 Jul-Aug;6(4):351-4. Epub 2015 Jul 1.
10
Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy.立体定向体部放疗期间 I 期非小细胞肺癌体积的变化
Radiat Oncol. 2014 Jan 7;9:8. doi: 10.1186/1748-717X-9-8.

本文引用的文献

1
Regression curves of brain metastases after gamma knife irradiation: Difference by tumor and patient characteristics.伽玛刀照射后脑转移瘤的回归曲线:肿瘤和患者特征的差异。
Cancer Sci. 2012 Nov;103(11):1967-73. doi: 10.1111/j.1349-7006.2012.02392.x. Epub 2012 Sep 18.
2
Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study.基于放射生物学方案的立体定向体部放疗治疗Ⅰ期非小细胞肺癌:一项多中心研究。
Cancer. 2012 Apr 15;118(8):2078-84. doi: 10.1002/cncr.26470. Epub 2011 Aug 25.
3
Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.利用乏氧 PET 成像和氧敏感电极进行辐射反应评估:一项临床前研究。
Radiother Oncol. 2011 Jun;99(3):418-23. doi: 10.1016/j.radonc.2011.06.034. Epub 2011 Jul 1.
4
Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer.立体定向体部放疗(SBRT)治疗结直肠癌和其他原发性癌症寡转移肺肿瘤与原发性肺癌的比较。
Radiother Oncol. 2011 Nov;101(2):255-9. doi: 10.1016/j.radonc.2011.05.033.
5
Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency.立体定向放疗原发性肺癌及其他病灶:国际原子能机构顾问会议结果。
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):660-9. doi: 10.1016/j.ijrobp.2010.10.004.
6
The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study.放疗治疗头颈部鳞状细胞癌(HNSCC)患者的血红蛋白水平的重要性和输血的影响——来自随机 DAHANCA 5 研究的结果。
Radiother Oncol. 2011 Jan;98(1):28-33. doi: 10.1016/j.radonc.2010.09.024. Epub 2010 Oct 20.
7
Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size.根据肿瘤大小采用不同剂量立体定向体部放疗治疗Ⅰ期非小细胞肺癌的临床结果。
Radiat Oncol. 2010 Sep 17;5:81. doi: 10.1186/1748-717X-5-81.
8
Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.采用新型照射技术(患者自主控制屏气及结合直线加速器和CT扫描仪的射野切换)对Ⅰ期非小细胞肺癌进行立体定向放射治疗的临床疗效
Lung Cancer. 2004 Jul;45(1):45-55. doi: 10.1016/j.lungcan.2004.01.004.
9
Blood hemoglobin level and treatment outcome of early breast cancer.早期乳腺癌的血血红蛋白水平与治疗结果
Strahlenther Onkol. 2004 Jan;180(1):45-51. doi: 10.1007/s00066-004-1123-7.
10
Prognostic factors in definitive radiotherapy of uterine cervical cancer.子宫颈癌根治性放射治疗的预后因素
Eur J Gynaecol Oncol. 2003;24(3-4):309-14.

立体定向放疗后 I 期非小细胞肺癌的早期反应和局部控制:组织学差异。

Early response and local control of stage I non-small-cell lung cancer after stereotactic radiotherapy: difference by histology.

机构信息

Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

出版信息

Cancer Sci. 2013 Jan;104(1):130-4. doi: 10.1111/cas.12048. Epub 2012 Dec 4.

DOI:10.1111/cas.12048
PMID:23095036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7657123/
Abstract

To investigate the possible influences of various factors on tumor response to radiation, regression speeds and long-term local control rates of primary adenocarcinoma and squamous cell carcinoma of the lung after stereotactic body radiotherapy were evaluated. Ninety-one patients (65 men and 26 women) with a median age of 76 years were serially examined using computed tomography at 2, 4 and 6 months after treatment. Tumor histology was adenocarcinoma in 62 patients and squamous cell carcinoma in 29 patients. The prescribed dose was 48 Gy in four fractions given twice a week for T1 tumors (≤ 3 cm) and 52 Gy in four fractions given twice a week for T2 tumors (3-5 cm). Tumor shrinkage speed and 3-year local control rates were similar between T1 and T2 tumors and between patients with normal pulmonary function and those with impaired function. Squamous cell carcinomas shrank faster than adenocarcinomas at 2 and 4 months after radiation, but mean relative tumor size at 6 months and local control rates at 3 years did not differ significantly between the two histologies. Tumors in patients with a higher hemoglobin level tended to shrink faster but the control rates were not different. It is concluded that, although squamous cell carcinoma shrinks faster than adenocarcinoma, the two types of lung cancer are of similar radiosensitivity in terms of long-term control rates. Radiosensitivity should not be evaluated by early tumor response.

摘要

为了研究各种因素对肿瘤放疗反应的可能影响,我们评估了立体定向体部放疗后原发性肺腺癌和鳞癌的回归速度和长期局部控制率。91 例患者(65 例男性,26 例女性),中位年龄为 76 岁,在治疗后 2、4 和 6 个月分别通过 CT 进行连续检查。肿瘤组织学为腺癌 62 例,鳞癌 29 例。T1 肿瘤(≤3cm)处方剂量为 48Gy 分 4 次,每周 2 次;T2 肿瘤(3-5cm)处方剂量为 52Gy 分 4 次,每周 2 次。T1 和 T2 肿瘤之间、肺功能正常和受损患者之间,肿瘤退缩速度和 3 年局部控制率相似。鳞癌在放疗后 2 个月和 4 个月时比腺癌退缩更快,但 6 个月时平均相对肿瘤大小和 3 年局部控制率在两种组织学类型之间无显著差异。血红蛋白水平较高的患者肿瘤往往退缩更快,但控制率无差异。结论:虽然鳞癌比腺癌退缩更快,但就长期控制率而言,两种肺癌的放射敏感性相似。不应通过早期肿瘤反应来评估放射敏感性。